3rd Circ. Panel Questions Niaspan Buyers' Class Data
A Third Circuit panel on Tuesday raised a number of questions for Niaspan buyers about the data supporting their bid for class status in a case accusing AbbVie and Teva Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article